StockGlow

Klaria Pharma Holding AB (publ.) (KLAR.ST)

Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

0.86+0.05%Healthcare
Compare KLAR.ST with
StockGlow Score
73
Leaning Bullish
BearishBullish
1 year ago+75.5%

The outlook

Klaria Pharma Holding AB (publ.) currently reads as leaning bullish based on above its 50- & 200-day averages, 47% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range47% of the way from its 52-week low to high
Market cap
$211.5M
52-wk high
1.33
52-wk low
0.44
50-day avg
0.79
200-day avg
0.79
Trailing P/E
—

Similar stocks

CANTA.STCantargia AB (publ)$1.82+0.33%ENZY.STEnzymatica AB (publ)$1.86-1.85%CLBIO.STCorline Biomedical AB$17.50-1.41%ATORX.STAlligator Bioscience AB (publ)$0.04+4.14%XBRANE.STXbrane Biopharma AB (publ)$10.15-1.46%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy